Rezultati - Li‐Tzong Chen
- Showing 1 - 20 results of 45
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
P-287 Nanoliposomal irinotecan (nal-IRI)-containing regimens versus nab-paclitaxel plus gemcitabine as first-line therapy in patients with metastatic pancreatic adenocarcinoma (mPA... od Andrew, Dean, Ramesh, Ramanathan, Brooke, Belota, Bruce, Belanger, Deyaa, Adib, Eliel, Bayever, Li-Tzong, Chen
Izdano 2016Text -
6
-
7
-
8
-
9
-
10
-
11
NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors od Andrea Wang‐Gillam, Richard Hubner, Jens T. Siveke, Daniel D. Von Hoff, Bruce Belanger, Floris A. de Jong, Beloo Mirakhur, Li‐Tzong Chen
Izdano 2019Artigo -
12
-
13
Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori–positive gastric diffuse large B-cell lymphomas od Sung‐Hsin Kuo, Kun‐Huei Yeh, Ming‐Shiang Wu, Chung‐Wu Lin, Ping‐Ning Hsu, Hsiu-Po Wang, Li‐Tzong Chen, Ann‐Lii Cheng
Izdano 2012Artigo -
14
A phase II trial of regorafenib in patients with metastatic and/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17 od Chun‐Nan Yeh, Ming‐Huang Chen, Yen‐Yang Chen, Ching‐Yao Yang, Chueh‐Chuan Yen, Chin‐Yuan Tzen, Li‐Tzong Chen, Jen‐Shi Chen
Izdano 2017Artigo -
15
-
16
Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer od Changhoon Yoo, Do-Youn Oh, Hye Jin Choi, Masatoshi Kudo, Makoto Ueno, Shunsuke Kondo, Li-Tzong Chen, Motonobu Osada, Christoph Helwig, Isabelle Dussault, Masafumi Ikeda
Izdano 2020Artigo -
17
Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review od Li‐Tzong Chen, Do‐Youn Oh, Min‐Hee Ryu, Kun‐Huei Yeh, Winnie Yeo, Roberto Carlesi, Rebecca Cheng, Jong-Seok Kim, Mauro Orlando, Yoon‐Koo Kang
Izdano 2017Revisão -
18
Association of T-Cell Regulatory Gene Polymorphisms With Susceptibility to Gastric Mucosa-Associated Lymphoid Tissue Lymphoma od Tsu‐Yao Cheng, Jaw‐Town Lin, Li-Tzong Chen, Chia‐Tung Shun, Hsiu–Po Wang, Ming‐Tsan Lin, Tsang-En Wang, Ann‐Lii Cheng, Ming‐Shiang Wu
Izdano 2006Artigo -
19
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors od Benjamin Garmezy, Mitesh J. Borad, Rastilav Bahleda, Cesar A. Perez, Li‐Tzong Chen, Shumei Kato, Do‐Youn Oh, Paul Severson, Betty Y. Tam, Cheng S. Quah, James J. Harding
Izdano 2024Artigo -
20
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Cancer
Oncology
Gastroenterology
Biology
Confidence interval
Pathology
Chemotherapy
Colorectal cancer
Hazard ratio
Clinical endpoint
Surgery
Gene
Genetics
Cancer research
Randomized controlled trial
Alternative medicine
Immunotherapy
Placebo
Adverse effect
Clinical trial
Gemcitabine
Irinotecan
Nivolumab
Epigenetics
Hepatocellular carcinoma
Pancreatic cancer
Physics
Biochemistry